This info from the BBG website confirms that Fellner will remain at Celltech as Chairman in addition to his new post at BBG.
Also it states that he will be looking to consolidation:-
---------------------------------------------------------------------------
He will become Chairman of Celltech when his successor as Chief Executive Officer takes up his appointment, which is expected in early 2003.
Dr Peter Fellner commented:
"There is currently a significant opportunity to create value within the biotechnology sector, through the consolidation of companies with good R&D and/or pipeline products, which are hampered by high cost bases and inadequate financial resources. British Biotech has a strong balance sheet and high quality development skills upon which to build, and I very much look forward to helping create value for the company's shareholders."
Barrett (Bill stock quotes
Barrett (Bill stock charts
Follow this thread
